Among Physicians and Consumers, Utilization Could Be Higher

February 2011
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p58
Trade Publication
The article presents a report by CVS Caremark Corp. and researchers at Harvard University, Brigham Young University and Women's Hospital which reveals that although generic drug use is at record rates, doctors and consumers suggest that ample room exists for greater utilization in the U.S.


Related Articles

  • Plan design can raise utilization of generics.  // Chain Drug Review;12/7/2009, Vol. 31 Issue 21, p50 

    The article reports on the study conducted by CVS Caremark Corp. which indicates that an innovative pharmacy benefits plan design offers improvement on generic drug utilization.

  • CVS Caremark's generics dispensing push pays off.  // Chain Drug Review;4/22/2013, Vol. 35 Issue 7, p10 

    The article discusses an annual report of CVS Caremark Corp. which reveals that CVS's generics dispensing rate (GDR) has reduced the traditional drug spending of its commercial clients by 3.6 percent.

  • CVS Caremark Reports Strong Net Income Gain.  // MMR;9/23/2013, Vol. 30 Issue 15, p5 

    The article discusses the increase in the net income at CVS Caremark Corp. in 2013. It informs that net income experienced double-digit growth for both the quarter and the first half due to the introduction of generic drugs. It reports that in the pharmacy segment of the CVS, net revenue rose to...

  • CVS Speaks Up On Biogenerics.  // Chain Drug Review;12/6/2010, Vol. 32 Issue 21, p84 

    The article reports that CVS Caremark Corp. had proposed to U.S. Food and Drug Administration (FDA) to implement regulations that are needed to approve biogeneric drugs as specified under the Affordable Care Act.

  • Study eyes the impact of generics.  // Chain Drug Review;7/19/2010, Vol. 32 Issue 12, p6 

    The article reports on a study conducted for CVS Caremark Corp. on the impact of the generic drugs, in which it shows that U.S. states can save 100 million dollars for their Medicaid programs over the next many years by changing laws to make substitution of generics simpler and quicker.

  • Savvy Choices Help Rein In Spending.  // Chain Drug Review;10/28/2013, Vol. 35 Issue 17, p77 

    The article focuses on a report of the non-profit Health Care Cost Institute which reveals a decline in medical spending in the U.S. due to eight percent increase in the use of generic medications whereas 20.7 percent decrease in the use of brand name prescription medications.

  • Zone in on: Healthcare. Greb, Erik // Pharmaceutical Technology;Aug2010, Vol. 34 Issue 8, p23 

    The article presents a study, conducted by CVS Caremark, regarding the effect of state legislations to the health care system in the U.S. Study shows that states can save for about 100 million U.S. dollars in medical care due to the implementation of the medical-related laws. Moreover, it also...

  • Corporate United won't stop innovating. SODER, CHUCK // Crain's Cleveland Business;1/20/2014, Vol. 35 Issue 3, p0005 

    The article discusses Corporate United (CU) programs consisting of new methodologies for helping CU clients gain benefits. Topics include the CU program with CVS Caremark for the implementation of wellness programs, management of specialty and costly drugs and generic drug use. It also notes CU...

  • Umstellungen zwischen Lamotrigin-Pr�paraten bei Epilepsiepatienten. Carius, A.; Schulze-Bonhage, A. // Nervenarzt;Apr2010, Vol. 81 Issue 4, p423 

    An increasing number of second-generation antiepileptic drugs have become available as generics. There is an ongoing debate as to whether this opens up ways to save costs or if efficacy and tolerability of an established treatment are at stake. We here present a retrospective analysis of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics